-
Sat05Sep2026Wed09Sep2026
-
Thu24Sep2026Fri25Sep2026
-
Wed21Oct2026Sun25Oct2026
-
Thu29Oct2026Sat31Oct2026
-
Wed25Nov2026Fri27Nov2026
Latest News
Phase 3 trial results of ATEV in AV access published in...
Humacyte has announced the publication of one-year results from the V007 phase 3 clinical trial of the acellular tissue engineered vessel (ATEV) in arteriovenous...
Features
European aXess data: a step forward in an evolving field
Considering the impact of the latest data on a biosynthetic graft for haemodialysis, Bart Dolmatch (Palo Alto, USA) is optimistic but keen to see...
VASBI’s 2026 meeting to put spotlight on outcomes and ownership in...
The concept of shared ownership in the provision of vascular access for kidney disease patients requiring dialysis will be a key theme running through...
Videos
In the second installment of our two-part focus on the re-emergence of endoAVF systems during CX 2026, host Nick Inston (University Hospital Birmingham NHS...
